These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16441638)

  • 61. [The role of the variability of gonococci in the development of therapeutic-prophylactic measures in gonorrhea].
    Mavrov II; Gorisiuk AF
    Mikrobiol Zh (1978); 1987; 49(4):62-4. PubMed ID: 3150499
    [No Abstract]   [Full Text] [Related]  

  • 62. Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.
    Knapp JS
    Sex Transm Dis; 1998 Sep; 25(8):425-6. PubMed ID: 9773436
    [No Abstract]   [Full Text] [Related]  

  • 63. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 64. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ontario, 1992-1994.
    Harnett N; Brown S; Riley G; Terro R; Krishnan C
    Can Commun Dis Rep; 1995 Feb; 21(3):17-20; discussion 20-1. PubMed ID: 7881379
    [No Abstract]   [Full Text] [Related]  

  • 65. Ciprofloxacin-resistant gonorrhoea in South Africa.
    Moodley P; Sturm AW
    Lancet; 2005 Oct; 366(9492):1159. PubMed ID: 16198757
    [No Abstract]   [Full Text] [Related]  

  • 66. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis.
    Palmer HM; Young H; Martin IM; Ison CA; Spratt BG
    Sex Transm Infect; 2005 Oct; 81(5):403-7. PubMed ID: 16199740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spectinomycin in the treatment of gonorrhoea.
    Gil-Setas A; Navascues-Ortega A; Beristain X
    Euro Surveill; 2010 May; 15(19):pii/19568; author reply pii/19569. PubMed ID: 20483105
    [No Abstract]   [Full Text] [Related]  

  • 68. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
    Turner A; Gough KR; Jephcott AE; McClean AN
    Genitourin Med; 1995 Aug; 71(4):265-6. PubMed ID: 7590725
    [No Abstract]   [Full Text] [Related]  

  • 69. Emergence of multidrug-resistant Neisseria gonorrhoeae strains circulating worldwide.
    Tanaka M
    Int J Urol; 2012 Feb; 19(2):98-9. PubMed ID: 22168311
    [No Abstract]   [Full Text] [Related]  

  • 70. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    JAMA; 1994 Jun; 271(22):1733-4. PubMed ID: 8196105
    [No Abstract]   [Full Text] [Related]  

  • 71. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Bangladesh (2014 Update).
    Khanam R; Ahmed D; Rahman M; Alam MS; Amin M; Khan SI; Mayer KH; Azim T
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4418-9. PubMed ID: 27185804
    [No Abstract]   [Full Text] [Related]  

  • 72. From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    JAMA; 2000 Oct; 284(15):1917-9. PubMed ID: 11183745
    [No Abstract]   [Full Text] [Related]  

  • 73. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

  • 74. Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin.
    Kam KM; Lo KK; Chong LY; Au WF; Wong PY; Cheung MM
    Clin Infect Dis; 1999 May; 28(5):1165-6. PubMed ID: 10452657
    [No Abstract]   [Full Text] [Related]  

  • 75. Antibiotics sensitivity pattern of N. gonorrhoeae with special emphasis on norfloxacin and ciprofloxacin.
    Pai A; Kulkarni MG; Koppikar GV
    J Assoc Physicians India; 1999 Aug; 47(8):795-7. PubMed ID: 10778625
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Mar; 40(1):E179-81. PubMed ID: 27080026
    [No Abstract]   [Full Text] [Related]  

  • 77. Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa.
    Moodley P; Martin IM; Ison CA; Sturm AW
    J Clin Microbiol; 2002 Dec; 40(12):4567-70. PubMed ID: 12454153
    [TBL] [Abstract][Full Text] [Related]  

  • 78. From the Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
    JAMA; 2002 Dec; 288(23):2961-3. PubMed ID: 12492093
    [No Abstract]   [Full Text] [Related]  

  • 79. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increasing rates of quinolone-resistant Neisseria gonorrhoeae in Paris, France.
    Farhi D; Gerhardt P; Falissard B; Poupet H; Poyart C; Dupin N
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):818-21. PubMed ID: 17567314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.